These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10753844)

  • 1. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.
    Dankbar B; Padró T; Leo R; Feldmann B; Kropff M; Mesters RM; Serve H; Berdel WE; Kienast J
    Blood; 2000 Apr; 95(8):2630-6. PubMed ID: 10753844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
    Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
    Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.
    Bellamy WT
    Semin Oncol; 2001 Dec; 28(6):551-9. PubMed ID: 11740808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.
    Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F
    Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
    Bellamy WT; Richter L; Frutiger Y; Grogan TM
    Cancer Res; 1999 Feb; 59(3):728-33. PubMed ID: 9973224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.
    Bisping G; Leo R; Wenning D; Dankbar B; Padró T; Kropff M; Scheffold C; Kröger M; Mesters RM; Berdel WE; Kienast J
    Blood; 2003 Apr; 101(7):2775-83. PubMed ID: 12517814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VEGF and its receptors by myeloma cells.
    Kumar S; Witzig TE; Timm M; Haug J; Wellik L; Fonseca R; Greipp PR; Rajkumar SV
    Leukemia; 2003 Oct; 17(10):2025-31. PubMed ID: 14513053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Zhang L; Chen SL; Chen WM; Liu JW
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
    Hideshima T; Chauhan D; Podar K; Schlossman RL; Richardson P; Anderson KC
    Semin Oncol; 2001 Dec; 28(6):607-12. PubMed ID: 11740818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours.
    Speirs V; Atkin SL
    Br J Cancer; 1999 May; 80(5-6):898-903. PubMed ID: 10360672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
    Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects.
    Liu C; Okruzhnov Y; Li H; Nicholas J
    J Virol; 2001 Nov; 75(22):10933-40. PubMed ID: 11602733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
    Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
    J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
    Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
    Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the bone marrow microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Res; 2002 Nov; 17(11):1921-5. PubMed ID: 12412796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.